Introducing the first-ever Eyes On Practice Management 2026!
Take a closer look at how leading clinics are improving performance, increasing revenue, and delivering better patient experiences with guidance from leaders in the trenches of practice operations. Attend 5 interactive virtual sessions live on Saturday, June 27, and earn up to 5 free COPE-approved CE hours. Claim your spot today!
New Content
Reducing Treatment Burden in nAMD and DME With Tyrosine Kinase Inhibitors
Staff-Driven Contact Lens Sales: Turning Technicians Into Revenue Generators
River Falls, WI
Driving Better Patient Outcomes Through Collaborative Long-Term Management
Join Drs. Dierker and Shah in the third and final episode of Tailoring Referral Algorithms to Geographic Atrophy as they discuss effective shared-care models that include routine monitoring, co-management of dry age-related macular degeneration (AMD), and patient education on progression.
Eyes On Dry Eye 2026 – In the Hot Seat: A Live Q&A with Damon Dierker, OD, FAAO, Regarding All Things Dry Eye Disease (DED) - Episode #2
In this Q&A, Damon Dierker, OD, FAAO offers insights into the shift in our clinical understanding of DED, differentiating between ocular rosacea and MGD, and current DED treatments.
Nutrition's Role in Preventative Eyecare
Learn how optometrists can educate patients on and leverage nutrition to improve short- and long-term ocular health and patient care.
Topics
The OD's Guide to Cranial Nerve Palsy Diagnosis and Management
New IZERVAY findings link GA treatment to improved likelihood of retaining driving eligibility
Post hoc analysis demonstrates IZERVAY reduces risk of progressing to losing driving eligibility in GA patients.
Remidio's portable fundus camera offers point-of-care imaging
FDA-cleared and smartphone-based diagnostic device offers complete imaging for both eyes in less than 1 minute—across a wide range of clinical settings.
Preliminary data evaluates Astellas's RPE cell therapy for advanced GA
Presented at ARVO 2026, early 26- and 52-week safety phase 1b data from highlights notable visual gains in patients receiving ASP7317.
Advances in Stem Cell Therapy for Vision Restoration
Join Drs. Kitchens and Leng as they discuss the impact of AI on research and developments in stem cell therapies for the treatment of geographic atrophy.
Reducing Treatment Burden in nAMD and DME With Tyrosine Kinase Inhibitors
Join Drs. Singh and Adam as they discuss clinical trial data on the potential impact of tyrosine kinase inhibitors (TKIs) on retinal conditions like nAMD and DME.
Driving Better Patient Outcomes Through Collaborative Long-Term Management
Join Drs. Dierker and Shah in the third and final episode of Tailoring Referral Algorithms to Geographic Atrophy as they discuss effective shared-care models that include routine monitoring, co-management of dry age-related macular degeneration (AMD), and patient education on progression.
Clinical Specialties
Staff-Driven Contact Lens Sales: Turning Technicians Into Revenue Generators
Review the state and future of the soft contact lens market and how optometrists can empower practice staff to increase contact lens sales.
Collaborative Care Within the Industry: What Does It Mean To Be A KOL
Join Drs. Lang, Leung, and Dang as they discuss what it means to be a KOL and how to engage with industry with clinical integrity.
How Ophthalmologists Can Use AI for Optimizing Their Practice
Sit down with Dr. De Rojas as he discusses the current and future impact of artificial intelligence (AI) in ophthalmology and how he uses AI in his practice.
Careers
A Look at Optometry Salaries in 2026 with Calculator
Information Blocking: The Next Compliance Crisis for ODs
The Ultimate Guide to Continuing Education For Optometrists
Featured Writers
Become a WriterOphthalmic Medical Education Summit 2025: Optimizing Astigmatism Management With ZEISS VERACITY
Dr. Brandon Ayres, MD, and Julie Schallhorn, MD, MS, discuss optimizing astigmatism management in cataract surgery with VERACITY Surgery Planner.
